Blue Goat CyberBlue Goat CyberSMMedical Device Cybersecurity
    Start here
    Services
    • Medical Device Cybersecurity Consulting
    • FDA Premarket Cybersecurity Package
    • Medical Device Penetration Testing Services
    • FDA Deficiency Response
    • FDA Postmarket Cybersecurity
    • Medical Device Threat Modeling
    • eSTAR Cybersecurity Documentation Support
    See all services
    Products

    Blue Goat products

    • GoatWatch logoGoatWatchSBOM risk management for medical devices
    About
    Resources

    Learn

    • Blog
    • Podcast
    • Webinars
    • Talks & workshops
    • Glossary
    • FAQs

    Playbooks & Tools

    • Guides
    • Playbooks (PDF)
    • Infographics
    • Interactive Tools

    Signals & Proof

    • Goat FeedNew
    • News
    • Medical Device Security News
    • The Goat's Weekly
    • Case Studies
    • Proof / Receipts
    All resources, topic hubs, & collections →
    ⌘K
    Book Strategy SessionHow to prepare →
    Blue Goat Cyber

    Full-service medical device cybersecurity. We protect patients by securing connected medical devices from design through postmarket.

    275+ FDA submissions supported, zero cybersecurity rejections · Mission: 1,000 by 2028

    SDVOSB · Service-Disabled Veteran-Owned Small Business

    We sponsor 10 community projects →

    Services

    • FDA Premarket Cybersecurity Package
    • FDA Deficiency Response
    • Medical Device Threat Modeling
    • Medical Device Penetration Testing Services
    • FDA Postmarket Cybersecurity
    • All services →
    Services
    • FDA Premarket Cybersecurity Package
    • FDA Deficiency Response
    • Medical Device Threat Modeling
    • Medical Device Penetration Testing Services
    • FDA Postmarket Cybersecurity
    • All services →

    Company

    • About
    • Core values
    • Manifesto
    • Leadership
    • Why Us
    • Partners
    • Careers
    • Press
    • Press kit
    • Contact
    • Company overviewPDF
    Company
    • About
    • Core values
    • Manifesto
    • Leadership
    • Why Us
    • Partners
    • Careers
    • Press
    • Press kit
    • Contact
    • Company overviewPDF

    Resources

    • Blog
    • Guides
    • Podcast
    • Case studies
    • Monthly Pulse newsletter
    • All resources →
    Resources
    • Blog
    • Guides
    • Podcast
    • Case studies
    • Monthly Pulse newsletter
    • All resources →

    Get in touch

    • info@bluegoatcyber.com
    • 844-939-GOAT
    • Book a strategy session →
    • 1776 N Scottsdale Rd, Unit 727
      Scottsdale, AZ 85257Serving clients worldwide

    Follow

    © 2026 Blue Goat Cyber. All rights reserved.

    • Privacy
    • Terms
    • Cookies
    • Sitemap
    • Accessibility
    • CVD

    MedTech Cybersecurity · Since 2022

    Goat Feed · Guidance

    Mira Hormone Monitor, Mira Android App

    Successful exploitation of these vulnerabilities could allow an attacker to access unauthorized health profile information, make changes to health information, cause a denial-of-service condition, disclose session token information, and obtain control of user accounts.

    Back to the daily feed
    Guidance
    notablePublished August 11, 2026 at 4:34 PM UTC
    Blue Goat take· Blue Goat Cyber Research

    These vulnerabilities indicate a failure to secure the communication bridge between home-use hardware and mobile platforms, allowing remote actors to seize full control of patient accounts. Direct-to-consumer fertility monitor manufacturers with high-volume Android user bases are most exposed to this risk of unauthorized health data manipulation. Firms must audit their session management and firmware update protocols to meet the FDA postmarket cybersecurity requirements for connected diagnostics.

    Blue Goat analysis

    Scored with Blue Goat's medical device cybersecurity risk methodology: STRIDE classification and CVSS v4.0 exploitability, with a severity-of-harm readout for your own ISO 14971 hazard analysis.

    Reviewed by Christian Espinosa, Founder & CEOOctober 30, 2026

    The Mira hormone monitor is a home device that measures hormone levels and syncs results through a mobile app and a cloud service. CISA's advisory covers eight vulnerabilities across all three: the device firmware (v1.7.1.47), the Android app (v4.5.15.4), and the cloud API. It's a clear example of why a connected device's threat model has to cover the app and the cloud, not just the hardware.

    CVEWhat an attacker can doSTRIDECVSS v4.0 ExploitabilitySecurity impact
    CVE-2026-68067The cloud API's login endpoint accepts any properly formatted string as the password (CWE-1390)SpoofingHighHigh
    CVE-2026-67568The distributed Android app embeds credentials that give an attacker read and write access (CWE-798)Information disclosure, TamperingHighHigh
    CVE-2026-66340The cloud authentication endpoints don't enforce per-account rate limiting (CWE-307)SpoofingHighMedium
    CVE-2026-66875An unauthenticated attacker within BLE range can silently rebind the device (CWE-306)Spoofing, TamperingMediumHigh
    CVE-2026-66098Any BLE central can write a value that reboots the device into bootloader mode, without authentication (CWE-306)Denial of serviceMediumHigh
    CVE-2026-67558The Android app identifies its paired analyzer by a substring match, so another device can impersonate it (CWE-290)SpoofingMediumHigh
    CVE-2026-66832In-app web content passes sensitive information in URL query strings (CWE-598)Information disclosureMediumHigh
    CVE-2026-64934The cloud API treats the firmware version reported by the app as an authorization input (CWE-807)Elevation of privilegeMediumMedium

    Three are network-reachable with no privileges and no user action, so Exploitability reads High. The rest need Bluetooth range, a user action, or a login, so they read Medium. On Blue Goat's security matrix, the two cloud authentication flaws (CVE-2026-68067 and CVE-2026-67568) are Critical, and five others are High, as published.

    The published vectors describe the product as CISA scored it, not your device. If you build on this product or a similar component, score your own deployment with the CVSS v4.0 environmental metrics before you rate your risk.

    At High exploitability:

    Severity from your hazard analysisSafety risk at High exploitability
    NegligibleMedium
    Minor or SeriousHigh
    Critical or CatastrophicVery High

    At Medium exploitability:

    Severity from your hazard analysisSafety risk at Medium exploitability
    NegligibleLow
    Minor or SeriousMedium
    Critical or CatastrophicHigh

    Hormone results guide personal health decisions. An attacker who can log in as any user, or change what the app shows, can expose or alter those results.

    What to check now

    1. Test your cloud login with malformed and arbitrary passwords, and confirm per-account rate limiting.
    2. Scan your mobile app builds for embedded credentials before every release.
    3. Bind app-to-device pairing to a cryptographic identity, not a name match.
    4. For Mira users, the fix is app iOS v3.5.18 or Android v4.5.18. Firmware v01.07.01.53 updates through the app when the device connects.
    5. If you're not affected, record that in a VEX statement with the justification.
    6. Re-score each affected threat in your cybersecurity risk assessment, and carry any patient-harm result into your ISO 14971 file.

    This analysis is informational. It is based on CISA's published advisory and does not assess any specific manufacturer's device.

    Related Goat Feed analysis

    Other items reviewed by the Blue Goat team.

    • Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT
    • Thermo Fisher Applied Biosystems Genetic Analyzers
    • Fourth Frontier Frontier X Mobile Application, Frontier X2
    • Pulsetto Vagus Nerve Stimulator (Update A)
    Citations
    • CISA ICS Medical Advisories
    • Methodology and sources →
    #icsma#advisory
    Need help acting on this?

    Talk to Blue Goat Cyber

    Penetration testing, SBOM, threat modeling, and 524B submission support for MedTech.

    Talk to usSee services